Melasma

Advances in Experimental Medicine and Biology

Volumn 455, Issue , 1999, Pages 491-499

  Kauh, Y C ^a   Zachian, T F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROQUINONE; METAHEXAMIDE; RETINOIC ACID; SUNSCREEN;

ADULT; CHLOASMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG POTENTIATION; FACE; FEMALE; HEREDITY; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; KOREA; LABORATORY TEST; NECK; PREGNANCY; PRIORITY JOURNAL; RACE; SIDE EFFECT; SKIN; SKIN BIOPSY; SKIN DEFECT; SUN EXPOSURE;

MELASMA;

EID: 0033282365     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4857-7_72     Document Type: Conference Paper

References (9)

1. Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence study
2. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial
3. Studies on clinical findings of melasma patient and psychosomatic health status
4. Usefulness of retinoic acid in the treatment of melasma
5. A new formula for depigmenting human skin
6. Combination of 4-hydroxyanisole and all-trans retinoic acid produces synergistic skin depigmentation in swine
7. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines
8. Cosmetics and dermatology: Bleaching creams
9. Daily topical sequential triple therapy of tretinoin, betamethasone valerate and hydroquinone on Melasma